ClinicalTrials.gg
Not yet recruitingNCT07228299SF-ICUUpdated Aug 27, 2026

Supporting Families in the ICU

An interventional study of Spiritual Care Assessment and Intervention (SCAI) Framework and ICU Guide in Anxiety, Well-Being and Satisfaction, sponsored by Indiana University. Not yet recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Indiana University · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The overarching goal of our work is to test the effect of high-quality spiritual care for ICU family surrogates on outcomes of psychological and spiritual well-being and medical decision making. Our team has developed an approach to high quality spiritual care intervention for ICU surrogates, called the Spiritual Care Assessment and Intervention (SCAI) framework, which is delivered by a chaplain interventionist to ICU surrogates.

Read the detailed description

To prepare for a fully powered, multi-center study, we propose a 2-arm, attention controlled, randomized pilot trial of high-quality spiritual care for 64 surrogates at 2 additional US medical centers.

Specific Aims are:

  1. To determine the feasibility and acceptability of all aspects of the study, including enrollment, randomization, delivery of the SCAI framework (e.g., chaplain intervention) and attention control conditions, acceptability, and outcome assessments, in preparation for a larger, Stage III effectiveness trial.
  2. To test the effects of spiritual care on the primary outcome of anxiety (GAD-7) and the secondary outcomes of surrogate spiritual well-being and satisfaction with spiritual care (FACIT-Sp-non-illness version, Satisfaction with Care-Chaplain), and decision making for the patient, including the process of decision making and the medical care received by the patient.
  3. To study the experience of spiritual care from the perspective of surrogates who are religious and those who are not, those of different faiths, and those who describe themselves as spiritual but not religious.

Because chaplains are common in the ICU this intervention is highly scalable. Results will guide hospital leaders, policy makers and the healthcare team regarding how to deploy chaplains to improve surrogates' psychological and spiritual health and the quality of decisions for critically ill patients.

02

Conditions studied

  • Anxiety
  • Well-Being
  • Satisfaction

Browse trials for

Keywords

  • spirituality
  • religion
  • surrogate decision making
  • proxy decision making
  • chaplain
03

In context

Anxiety Disorders Unverified

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

This study's planned enrollment of 64 is below the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Indiana University is the lead sponsor of 991 studies on the registry; 202 are open to participants now.

Of its 150 completed or terminated interventional studies of FDA-regulated products, 118 (79%) have results posted.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

We will enroll patient/surrogate dyads.

Patients will be eligible if:

  • They are age 18 or older at the time of screening.
  • They are judged to lack decisional capacity based on either:

a Glasgow Coma Scale (GCS) score of 8 or less; or a GCS of 9-13 with at least one secondary criterion (intubation, sedation, delirium, or noted by clinicians to be unresponsive, comatose or unable to follow commands).

* They have an eligible surrogate willing to participate.

Surrogates will be eligible if:

  • They are age 18 or older,
  • They are considered the legally authorized representative (LAR) based on prior appointment by the patient or each state's medical consent law.

Patient/surrogate dyads will be ineligible if:

* They are unable to complete enrollment activities within 96 hours of admission to the ICU.

Patients will be ineligible if:

  • They are being discharged from the ICU within 24 hours.
  • They are intubated for surgery but expected to be extubated soon (typically within 24 hours).
  • They are imminently dying or have a planned terminal wean.

Surrogates will be ineligible if:

*They are unable to complete study procedures in English.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Intervention (SCAI Framework)

    Participants in this arm will receive the chaplain led intervention of the Spiritual Care Assessment and Intervention (SCAI) framework.

    Behavioral: Spiritual Care Assessment and Intervention (SCAI) Framework

  • Active comparator
    Control (ICU Guide)

    Participants in this arm will participate in meetings with a member of the research team to review an ICU guide.

    Behavioral: ICU Guide

Interventions

  • BehavioralSpiritual Care Assessment and Intervention (SCAI) Framework

    The SCAI intervention includes three visits generally scheduled 48-72 hours apart. After three visits, the chaplain will contact the surrogate at least weekly for the remainder of the hospitalization. If the patient dies, the chaplain will conduct a bereavement visit. The SCAI framework addresses four dimensions of spirituality. If all four dimensions are not addressed, they may be assessed during follow-up visits. If all four dimensions are addressed during the initial visit, other visits include at least one question from any dimension. The SCAI framework includes a list of common spiritual care interventions developed based on clinical experience and literature review.. Based on our conceptual framework, interventions are either are emotionally supportive, address spiritual or religious dimensions of care, or address information support such as exploring the meaning of medical events. Consistent with chaplain standards, the chaplain selects and tailors these interventions.

  • BehavioralICU Guide

    The ICU Guide intervention will include three visits with the site RA that are similar in duration to the chaplain visits (based on the single center study, first visit median of 23 minutes, follow-up visit median 12 minutes), with review of a brochure introducing the family member to the ICU including staff, policies and procedures that will be helpful to the family member.

06

What researchers measure

Primary outcomes

  1. Effect of the intervention on surrogate anxiety (GAD-7)

    Generalized Anxiety Disorder- 7 (GAD-7) (7 item inventory of anxiety)- assesses subject's self-reported anxiety for the last two weeks. Scores range from 0-21 0= 'Not at all'; 1= 'Several Days'; 2= 'More than half the days'; 3= 'Nearly every day' Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater. Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for GAD.

    Time frame: Assessed at baseline and 6-8 weeks after the patient has discharged from the hospital

Secondary outcomes

  1. Effect of the intervention on surrogate spiritual well-being (FACIT-Sp)

    Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT- Sp) Scale, a 12-item questionnaire used to measure spiritual well-being in people with chronic illnesses. It assesses aspects like meaning, peace, and faith, and is widely used in research and clinical settings, particularly for patients with cancer and other serious health conditions.

    Time frame: Assessed at baseline and 6-8 weeks after the patient has discharged from the hospital

  2. Decision making quality (FS-ICU)

    Family Satisfaction with the ICU Process of Decision Making Subscale, a 4 item inventory of decision making quality

    Time frame: Assessed 6-8 weeks after the patient has discharged from the hospital

  3. Satisfaction with Spiritual Care (PSI-C)

    Patient Satisfaction Instrument- Chaplaincy includes 23 clinical statements which are rated on a 4 (strongly agree) to 1 (strongly disagree) scale.

    Time frame: Assessed 6-8 weeks after the patient has discharged from the hospital

Other outcomes

  1. Hospice enrollment

    Total count of patients in both groups who enroll in hospice during the hospitalization

    Time frame: Assessed 3 months after the patient has discharged from the hospital

  2. ICU length of stay

    Total length of stay for patients in both groups

    Time frame: Assessed 3 months after the patient has discharged from the hospital

  3. DNR declaration

    Total count of patients in both groups who changed their code status to DNR during the hospitalization

    Time frame: Assessed 3 months after the patient has discharged from the hospital

  4. Comfort plan initiation

    Total count of patients in both groups who initiated a comfort plan during the hospitalization

    Time frame: Assessed 3 months after the patient has discharged from the hospital

  5. Receipt of life sustaining interventions

    Total count of patients in both groups who received life sustaining interventions during the hospitalization.

    Time frame: Assessed 3 months after the patient has discharged from the hospital

  6. Overall distress (Distress thermometer) during the ICU stay

    Total scores on distress thermometer (single item survey) will be tracked throughout the ICU stay. Text prompts using HIPAA compliant software will be sent.

    Time frame: Days 2, 4, and 6 after enrollment and two days weekly thereafter until discharge from the ICU, up to 3 weeks.

  7. Spiritual well being during the ICU stay

    Spiritual well being will be assessed using the at peace single item question of spiritual distress. Text prompts using HIPAA compliant software will be sent.

    Time frame: Days 2, 4, and 6 after enrollment and two days weekly thereafter until discharge from the ICU, up to 3 weeks.

  8. Decision making quality during the ICU stay for participants who make a medical decision

    Decision making quality scores will be based on responses to the Decisional Conflict Scale (DCS) Effective Decisions Subscale, a validated four item survey of medical decision making quality in the hospital. Scores range from 0 to 4 on each item. Scores range from 0 to 16. Higher scores indicate better decision quality. Text prompts using HIPAA compliant software will be sent.

    Time frame: Days 2, 4, and 6 after enrollment and weekly thereafter until discharge from the ICU, up to 3 weeks, for those who endorse making a medical decision.

  9. Depression (PHQ-2) during the ICU stay

    Depression scores will be assessed using the validated 2-item version of the Patient Health Questionnaire-2. Scores range from 0 to 3 for each item. Total scores range from 0 to 6. Higher scores indicate higher likelihood of depression. Text prompts using HIPAA compliant software will be sent.

    Time frame: Days 1, 3, 5, and 7 after enrollment and weekly thereafter until discharge from the ICU, up to 3 weeks.

  10. Anxiety (GAD-2) during the ICU stay

    Anxiety scores will be assessed using the validated 2-item version of the Generalized Anxiety Disorder-2. Scores range from 0 to 3 for each item. Total scores range from 0 to 6. Higher scores indicate higher likelihood of anxiety. Text prompts using HIPAA compliant software will be sent.

    Time frame: Days 1, 3, 5, and 7 after enrollment and weekly thereafter until discharge from the ICU, up to 3 weeks.

  11. Communication quality (FICS-5) during the ICU stay

    Communication quality scores will be based on responses to the Family Inpatient Communication Survey-5, a validated five item survey of communication quality in the hospital. Scores range from 1 to 5 for each item. Total scores range from 5 to 25. Higher scores indicate better communication quality in the hospital. Text prompts using HIPAA compliant software will be sent.

    Time frame: Days 1, 3, 5, and 7 after enrollment and weekly thereafter until discharge from the ICU, up to 3 weeks.

  12. Acceptability of the Intervention (AIM)

    The acceptability of the intervention measure (AIM) is a 4 item scale. Scores range from 1 to 5 for each item. Total scores range from 4 to 20. Higher scores indicate greater acceptability of the intervention.

    Time frame: Assessed 6-8 weeks after the patient has discharged from the hospital

  13. Acceptability of psychological interventions (TAAS)

    The Treatment Acceptability and Adherence Scale (TAAS) is a 10 item scale developed to measure the acceptability of psychological interventions. Scores range from 1 to 7 for each item. Total scores range from 10 to 70. Higher scores indicate greater treatment acceptability and adherence.

    Time frame: Assessed 6-8 weeks after the patient has discharged from the hospital

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 12 months is close to that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2025
First posted
Nov 14, 2025
StartEst.
Nov 1, 2026
Primary completionEst.
Nov 1, 2027
CompletionEst.
Nov 1, 2027
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07228299
Lead sponsor
Indiana University
Responsible party
Alexia M. Torke (Professor of Medicine, Indiana University) — Principal investigator
First posted
Nov 14, 2025
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 1, 2027 (estimated)
Completion
Nov 1, 2027 (estimated)
Last update
Aug 27, 2026

Study contacts

Emily S Burke, BA
Contact
burkee@ohsu.edu
317-274-9047
Alexia M Torke, MD, MS
Contact
torke@ohsu.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion